A literature review: Overview of drug-resistant tuberculosis and preventive and control policies of tuberculosis transmission in Thailand

Main Article Content

Jidapa Pinkunakorn

Abstract

Tuberculosis has been one of the major causes of death for a long period of time, mainly in underdeveloped nations, where drug-resistant tuberculosis is prevalent. There are numerous challenges in Thailand that obstruct the performance of tuberculosis treatment. As a consequence, all problems and contemporary tuberculosis transmission prevention and control policies in the country should be investigated in an attempt to lessen the impediments that prohibit beneficial results. The purpose of this study was to examine an overview of Thailand's drug-resistant tuberculosis data and to suggest strategies to minimize drug-resistant tuberculosis transmission. The study was conducted by reviewing the academic literature and research papers related to tuberculosis that published between 2010 and 2022 including definition, causes, types, regimens, preventions, and the main causes that contribute to the increase in infection rates and death tolls. As a result, there are several issues that cause tuberculosis to widely spread and develop to drug-resistant tuberculosis. Some of the most worrisome problems are the unawareness of being infected, detachment from the proper treatment associated with the socioeconomic factors, and the decision of patients themselves to cease the usage of anti-tuberculosis drugs without physicians’ allowance. Consequently, Raising the awareness of the people in the public society, which can be done by providing the critical information about tuberculosis, will assist in increasing the personal protection that will help to dwindle the tuberculosis infection rate. Some of the policies can be improved for the best result. For example, the BCG vaccination supply, the active case finding, transferring the patients to the medication system, educating people about the danger of tuberculosis, and wearing masks whenever inhabiting in congested areas.

Article Details

How to Cite
1.
Pinkunakorn J. A literature review: Overview of drug-resistant tuberculosis and preventive and control policies of tuberculosis transmission in Thailand. IUDCJ [Internet]. 2022 Aug. 30 [cited 2024 Dec. 22];7(1):75-91. Available from: https://he01.tci-thaijo.org/index.php/iudcJ/article/view/255872
Section
Review Articles

References

World Health Organization. Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic [Internet]. [cited on 26 Nov 2021]. Available from: https://www.who.int/news/item/14-10-2021-tuberculosis-deaths-rise-for-the-first-time-in-more-than-a-decade-due-to-the-covid-19-pandemic

World Health Organization. Tuberculosis [Internet]. [cited on 26 Nov 2021]. Available from: https://www.who.int/health-topics/tuberculosis#tab=tab_1

World Health Organization. Global tuberculosis report 2019 [Internet]. [cited on 26 Nov 2021]. Available from: https://www.who.int/publications/i/item/9789241565714

New York State Department of Health. Tuberculosis(TB) [Internet]. [cited on 27 Nov 2021]. Available from: https://www.health.ny.gov/diseases/communicable/tuberculosis/docs/fact_sheet.pdf

Website of the Global Tuberculosis Community Advisory Board. Thailand: Thousands with TB lack treatment [Internet]. [cited on 27 Nov 2021]. Available from: https://www.tbonline.info/posts/2014/3/21/thailand-thousands-tb-lack-treatment/#

Centers for Disease Control and Prevention. Drug-Resistant TB [Internet]. [cited on 26 Nov 2021]. Available from: https://www.cdc.gov/tb/topic/drtb/default.htm

The Global Fund. Why drug-resistant tuberculosis poses a major risk to global health security [Internet]. [cited on 29 Nov 2021]. Available from: https://www.theglobalfund.org/en/blog/2020-11-19-why-drug-resistant-tuberculosis-poses-a-major-risk-to-global-health-security

Florence O. Bada, Nick Blok, Evaezi Okpokoro et al. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria. PLoS One. 15(12); Dec 2020.

กองวัณโรค กรมควบคุมโรค. โครงการซื้อยา Bedaquiline ขนาด 100mg ขนาดบรรจุกล่องละ 188 เม็ด จำนวน 50 กล่อง โดยวิธีเฉพาะเจาะจง ตามมาตรา 56(2)(ค) [Internet]. [cited on 29 Nov 2021]. Available from: http://ddccenter.ddc.moph.go.th/infoc/download/202012171608193128_Scan2563-12-17_151359.pdf

Centers for Disease Control and Prevention. Chapter 2: Transmission and Pathogenesis of Tuberculosis [Internet]. [cited on 30 Nov 2021]. Available from: https://www.cdc.gov/tb/education/corecurr/pdf/chapter2.pdf

สมาคมโรคติดเชื้อในเด็กแห่งประเทศไทย. แนวทางการรักษาวัณโรคดื้อยา ตามคำแนะนำของสมาคมโรคติดเชื้อ สมาคมโรคทรวงอกประเทศสหรัฐอเมริกา และสมาคมโรคทางเดินหายในสหภาพยุโรป ปี พ.ศ. 2562 [Internet]. [cited on 30 Nov 2021]. Available from: https://www.pidst.or.th/A919.html

Centers for Disease Control and Prevention. Deciding When to Treat Latent TB Infection [Internet]. [cited on 1 Dec 2021]. Available from: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiNkdyC_9T3AhVJS2wGHSUaBiIQFnoECAoQAw&url=https%3A%2F%2Fwww.cdc.gov%2Ftb%2Ftopic%2Ftreatment%2Fdecideltbi.htm&usg=AOvVaw1mQPd2rJQOPerHGLG3-KLE

กองวัณโรค กรมควบคุมโรค. คำแนะนำเรื่องการวินิจฉัยและรักษาการติดเชื้อวัณโรคระยะแฝง [Internet]. [cited on 2 Dec 2021]. Available from: https://www.tbthailand.org/download/Manual/คำเเนะนำเรื่องการวินิจฉัยและรักษาการติดเชื้อวัณโรคระยะแฝง.pdf

Bangkok Post. Thailand's fight against drug-resistant tuberculosis [Internet]. [cited on 5 Dec 2021]. Available from: https://www.bangkokpost.com/thailand/special-reports/427154/thailand-fight-against-drug-resistant-tuberculosis

Rajendra Prasad, Nikhil Gupta, and Mandeep Singh. Multidrug resistant tuberculosis: trends and control. Indian J Chest Dis Allied Sci. 56(4); Oct-Dec 2014; 237-46.

สำนักวัณโรค กรมควบคุมโรค. แนวทางการควบคุมวัณโรคประเทศไทย พ.ศ.2561 [Internet]. [cited on 5 Dec 2021]. Available from: https://www.tbthailand.org/download/Manual/NTP2018.pdf

Centers for Disease Control and Prevention. Adverse Events [Internet]. [cited on 6 Dec 2021]. Available from: https://www.cdc.gov/tb/topic/treatment/adverseevents.htm

Yiyuan Li, Yu Zhu, Qin Zhong et al. Serious Adverse Reactions From Anti-tuberculosis Drugs Among 599 Children Hospitalized for Tuberculosis. Pediatr Infect Dis J. 36(8); Aug 2017; 720-725.

Qian Long, Helen Smith, Tuohong Zhang et al. Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC Public Health 11.

Anne M Doherty, John Kelly, Colm McDonald et al. A review of the interplay between tuberculosis and mental health. Gen Hosp Psychiatry. 35(4); Jul-Aug 2013; 398-406.

World Health Organization Regional Office for Europe. Drug-resistant tuberculosis (DR-TB) [Internet]. [cited on 8 Dec 2021]. Available from: https://www.euro.who.int/en/health-topics/communicable-diseases/tuberculosis/areas-of-work/drug-resistant-tuberculosis-dr-tb

Habteyes Hailu TOLA, Azar TOL, Davoud SHOJAEIZADEH et al. Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review. Iran J Public Health. 44(1); Jan 2015; 1–11.

Stella Arakelyan, Aaron S Karat, Annie SK Jones et al. Relational Dynamics of Treatment Behavior Among Individuals with Tuberculosis in High-Income Countries: A Scoping Review. Patient Preference and Adherence. 15; Sep 2021; 2137–2154.

Sundari R. Mase and Terence Chorba. Treatment of Drug-Resistant Tuberculosis. Clin Chest Med. 40(4); Dec 2019; 775–795.

Encyclopædia Britannica. BCG vaccine [Internet]. [cited on 10 Dec 2021]. Available from: https://www.britannica.com/science/BCG-vaccine

TB Alert (the UK’s national tuberculosis charity). TB prevention [Internet]. [cited on 10 Dec 2021]. Available from: https://www.tbalert.org/about-tb/what-is-tb/prevention/

Jose A. Caminero and Anna Scardigli. Tuberculosis in children: Challenges and opportunities.

An Pediatr (Barc). Dec 2016; 281-283.